Literature DB >> 1301130

Statistical analysis of longitudinal quality of life data with missing measurements.

A H Zwinderman1.   

Abstract

The statistical analysis of longitudinal quality of life data in the presence of missing data is discussed. In cancer trials missing data are generated due to the fact that patients die, drop out, or are censored. These missing data are problematic in the monitoring of the quality of life during the trial. However, by means of assuming that the cause of the missing data lies in the observed history of the patients and not in their unobserved future, the missing data are ignorable. Consequently, all available data can be used to estimate quality of life change patterns with time. The computations that are required are illustrated with real quality of life data and three commonly used computer packages for statistical analysis.

Entities:  

Mesh:

Year:  1992        PMID: 1301130     DOI: 10.1007/bf00635621

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  5 in total

1.  The measurement of change of quality of life in clinical trials.

Authors:  A H Zwinderman
Journal:  Stat Med       Date:  1990-08       Impact factor: 2.373

2.  The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer.

Authors:  A T van Holten-Verzantvoort; A H Zwinderman; N K Aaronson; J Hermans; B van Emmerik; F S van Dam; B van den Bos; O L Bijvoet; F J Cleton
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

Review 3.  Assessment of quality of life in clinical trials.

Authors:  M Schumacher; M Olschewski; G Schulgen
Journal:  Stat Med       Date:  1991-12       Impact factor: 2.373

Review 4.  Measuring the quality of life of cancer patients: psychometric properties of instruments.

Authors:  F C van Knippenberg; J C de Haes
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

5.  Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment.

Authors:  A T van Holten-Verzantvoort; O L Bijvoet; F J Cleton; J Hermans; H M Kroon; H I Harinck; P Vermey; J W Elte; J P Neijt; L V Beex
Journal:  Lancet       Date:  1987-10-31       Impact factor: 79.321

  5 in total
  11 in total

1.  Missing data methods for dealing with missing items in quality of life questionnaires. A comparison by simulation of personal mean score, full information maximum likelihood, multiple imputation, and hot deck techniques applied to the SF-36 in the French 2003 decennial health survey.

Authors:  Hugo Peyre; Alain Leplège; Joël Coste
Journal:  Qual Life Res       Date:  2010-10-01       Impact factor: 4.147

2.  Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial.

Authors:  P Hopwood; R J Stephens; D Machin
Journal:  Qual Life Res       Date:  1994-10       Impact factor: 4.147

3.  Integrating Quality of Life and Survival Outcomes in Cardiovascular Clinical Trials.

Authors:  Jacob V Spertus; Laura A Hatfield; David J Cohen; Suzanne V Arnold; Martin Ho; Philip G Jones; Martin Leon; Bram Zuckerman; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-06-13

4.  Quality of life bibliography and indexes: 1993 update.

Authors:  R A Berzon; G P Simeon; R L Simpson; M A Donnelly; H H Tilson
Journal:  Qual Life Res       Date:  1995-02       Impact factor: 4.147

5.  Estimating the effect of treatment on quality of life in the presence of missing data due to drop-out and death.

Authors:  J M Raboud; J Singer; A Thorne; M T Schechter; S D Shafran
Journal:  Qual Life Res       Date:  1998-08       Impact factor: 4.147

6.  Identifying type and determinants of missing items in quality of life questionnaires: Application to the SF-36 French version of the 2003 Decennial Health Survey.

Authors:  Hugo Peyre; Joël Coste; Alain Leplège
Journal:  Health Qual Life Outcomes       Date:  2010-02-03       Impact factor: 3.186

Review 7.  MRC quality of life studies using a daily diary card--practical lessons learned from cancer trials.

Authors:  P Fayers
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

8.  Cancer symptom response as an oncology clinical trial end point.

Authors:  Laura C Bouchard; Neil Aaronson; Kathleen Gondek; David Cella
Journal:  Expert Rev Qual Life Cancer Care       Date:  2018-06-07

9.  Quality of life assessment in clinical cancer research.

Authors:  M Olschewski; G Schulgen; M Schumacher; D G Altman
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

10.  Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above.

Authors:  Desmond Curran; Ruprecht Schmidt-Ott; Ulf Schutter; Jörg Simon; Anastassia Anastassopoulou; Sean Matthews
Journal:  BMC Infect Dis       Date:  2018-10-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.